Akzo Nobel Escapes $421M Medicaid Kickback Suit

Law360, New York (April 3, 2012, 3:57 PM EDT) -- A federal judge agreed on Friday to dismiss a False Claims Act case filed by employee whistleblowers against Akzo Nobel NV, the former parent of Organon USA Inc., a pharmaceutical company accused of operating a kickback scheme that helped overcharge Medicaid by $421 million.

While U.S. District Judge Rya W. Zobel of Massachusetts federal court dismissed the claims against Akzo Nobel for lack of jurisdiction, the claims against several other defendants, including Organon, Merck & Co. Inc. and Schering Plough Corp., are still pending.

Organon and...
To view the full article, register now.




Case Information

Case Title

United States of America et al v. Organon USA Inc et al

Case Number




Nature of Suit

Other Statutory Actions


Rya W. Zobel

Date Filed

November 16, 2007

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.